TGA

The Australian Therapeutic Goods Administration (TGA) has approved Eylea 8mg, a higher dose of aflibercept for adults with neovascular aged-related...

Medtech company Eyerising International Pty Ltd has announced its myopia management device – based on repeated low-level red-light (RLRL) technology...

The Therapeutic Goods Administration (TGA) has approved a new AI software system that can screen for three major eye diseases...

The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children...

The Therapeutic Goods Administration (TGA) has granted Lucentis (ranibizumab) an indication for retinopathy of prematurity (ROP), making it the first...

In a historical development for the eye health sector, the Therapeutics Goods Administration (TGA) has approved the country’s first true...